![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 5-azacytidine | increases expression | EXP | | 6480464 | Azacitidine results in increased expression of MYF5 mRNA | CTD | PMID:18938140 | 5-fluorouracil | affects expression | EXP | | 6480464 | Fluorouracil affects the expression of MYF5 protein | CTD | PMID:21296659 | acetic acid | decreases expression | EXP | | 6480464 | Acetic Acid results in decreased expression of MYF5 protein | CTD | PMID:21296659 | amiloride | increases expression | ISO | RGD:1318025 | 6480464 | Amiloride results in increased expression of MYF5 mRNA | CTD | PMID:15535137 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to MYF5 promoter] | CTD | PMID:19654925 | bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of MYF5 mRNA | CTD | PMID:15674843 | bisphenol A | decreases expression | ISO | RGD:1308322 | 6480464 | bisphenol A results in decreased expression of MYF5 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of MYF5 promoter | CTD | PMID:27312807 | bisphenol A | affects methylation | EXP | | 6480464 | bisphenol A affects the methylation of MYF5 promoter | CTD | PMID:27334623 | bisphenol A | decreases methylation | ISO | RGD:1318025 | 6480464 | bisphenol A results in decreased methylation of MYF5 promoter | CTD | PMID:27271280 | bromochloroacetic acid | decreases expression | EXP | | 6480464 | bromochloroacetic acid results in decreased expression of MYF5 protein | CTD | PMID:21296659 | bupivacaine | decreases expression | ISO | RGD:1308322 | 6480464 | Bupivacaine results in decreased expression of MYF5 protein | CTD | PMID:10434046 | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of MYF5 mRNA | CTD | PMID:25149082 | cadmium atom | decreases expression | ISO | RGD:1318025 | 6480464 | Cadmium results in decreased expression of MYF5 mRNA | CTD | PMID:24376830 | chromium atom | decreases expression | ISO | RGD:1308322 | 6480464 | Chromium deficiency results in decreased expression of MYF5 mRNA | CTD | PMID:20404053 | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of MYF5 mRNA | CTD | PMID:22936724 | dorsomorphin | multiple interactions | ISO | RGD:1318025 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | genistein | decreases expression | ISO | RGD:1308322 | 6480464 | Genistein results in decreased expression of MYF5 mRNA | CTD | PMID:24361872 | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of MYF5 mRNA | CTD | PMID:12057914 | panobinostat | multiple interactions | ISO | RGD:1318025 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYF5 mRNA | CTD | PMID:27188386 | paracetamol | decreases expression | ISO | RGD:1318025 | 6480464 | Acetaminophen results in decreased expression of MYF5 mRNA | CTD | PMID:26690555 | Ptaquiloside | decreases expression | EXP | | 6480464 | ptaquiloside results in decreased expression of MYF5 mRNA | CTD | PMID:23274088 | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MYF5 protein | CTD | PMID:24330398 | SB 431542 | multiple interactions | ISO | RGD:1318025 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MYF5 mRNA | CTD | PMID:22641621 | spermine | increases expression | EXP | | 6480464 | Spermine results in increased expression of MYF5 mRNA | CTD | PMID:18673383 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of MYF5 mRNA | CTD | PMID:17292431 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of MYF5 mRNA | CTD | PMID:24896083 | valproic acid | increases expression | ISO | RGD:1318025 | 6480464 | Valproic Acid results in increased expression of MYF5 mRNA | CTD | PMID:24383497, PMID:24935251 | vorinostat | multiple interactions | ISO | RGD:1318025 | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYF5 mRNA | CTD | PMID:27188386 | |

Biological Process
Cellular Component
Molecular Function

Mammalian Phenotype